Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway

Cancer Gene Therapy, Published online: 11 March 2024; doi:10.1038/s41417-024-00754-yHeparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway

Source: Cancer Gene Therapy - March 11, 2024 Category: Cancer & Oncology Authors: Fengyan Yuan Huiqin Zhou Chongyang Liu Yi Wang Jing Quan Jie Liu Hao Li Mark von Itzstein Xing Yu Source Type: research